Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ipca Takes Full Ownership Of Bayshore

Strikes Deal To Acquire Remaining 20% Holding In US Generics Firm

Executive Summary

Ipca has struck a deal to take full ownership of US firm Bayshore Pharmaceuticals by acquiring the remaining 20% stake that it did not already own.

You may also be interested in...



Biosimilars Players Climb Global Rankings

Biosimilars players are gaining an increasing foothold in the off-patent industry, as demonstrated by the final part of our annual Top 50 ranking.

Ipca Adds To API Business By Acquiring Ramdev

India’s Ipca is boosting its API business with a deal to acquire local firm Ramdev Chemical for INR1.1bn in cash.

Ipca takes control of US player Bayshore

Ipca Laboratories has paid just under US$10.3 million in cash for 80% of the share capital in US generics player Bayshore Pharmaceuticals. The Indian company said that acquiring the majority stake in sales and marketing firm Bayshore through its wholly-owned US subsidiary Ipca Pharmaceuticals would “enable the firm to commercialise its registered generic drug products in the US market through this entity”.

Topics

Related Companies

UsernamePublicRestriction

Register

GB151295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel